PBS updates

Radicava (Edaravone)

edaravone 30 mg/20 mL injection, 10 x 20 mL ampoules · INJECTION · PBS code 15334C

AUTHORITY_REQUIRED

What it costs

AU$2200 PBS-determined price per 28 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2026-04-01.
  • • Repeats: 0.
  • • PBS program: CA.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Amyotrophic lateral sclerosis


Initial treatment


The condition must be/have been diagnosed by a neurologist; AND

Patient must not have had symptoms for more than 2 years prior to commencing therapy with this drug; AND

Patient must have at least 80 percent of predicted forced vital capacity (FVC) or slow vital capacity (SVC) within the 2 months prior to commencing therapy with this drug; AND

Patient must not require assistance with eating or ambulation prior to commencing treatment with this drug; AND

Patient must have at least two points on each individual item of the ALS Functional Rating Scale - Revised (ALSFRS-R) score prior to commencing therapy with this drug; AND

Patient must not have undergone a tracheostomy; AND

Patient must not have experienced respiratory failure.

The date of diagnosis, the date and results of spirometry (in terms of percent of predicted forced vital capacity or slow vital capacity) must be supplied with the initial authority application.

Prescribers must request a quantity sufficient to cover one month per dispensing, in accordance with the patient's treatment cycle. Prescribers must request a smaller number of units than the listed maximum quantity units if it is adequate for the patient's needs.

Sponsor: Teva Pharma Australia Pty Ltd ABN 41 169 715 664

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.